A sensitive flow-injection (FI) procedure with spectrophotometric detection in a micellar medium is proposed for the determination of novalgin. The method is based on the instantaneous formation of a red-orange product (λmax = 510 nm) after the reaction between novalgin and p-dimethylaminocinnamaldehyde (p-DAC) in a dilute acid medium. The sensitivity of this reaction was increased by a factor of 5.6 in the presence of sodium dodecyl sulfate (SDS). Experimental design methodologies were used to optimize the chemical and FI variables. The calibration curve was linear in the range of 1.45 × 10 -6 to 2.90 × 10 -5 mol L -1 with an excellent correlation coefficient (r = 0.9999). The detection limit was 1.31 × 10 -7 mol L -1 (n = 20, RSD = 2.0%). No interferences were observed from the common excipients. The results obtained by the proposed method were favorably compared with those given by the iodometric reference method at 95% confidence level.
Introduction
Novalgin (sodium salt of 1-phenyl-2,3-dimethyl-4-methylaminomethane sulfonate-5-pyrazolone; analgin, dipyrone, metamizol) is a pyrazolone derivate widely used as an analgesic, antipyretic and antispasmodic in several pharmaceutical formulations. 1 It was introduced into clinical practice in 1922. Due to its strong analgesic effect, available parenteral formulation and low cost, novalgin is extensively used in many countries. 2, 3 Various methods have been established for the quantitative determination of novalgin in pharmaceutical formulations including titrimetry in aqueous 4, 5 and non-aqueous 6 media, HPLC with UV detection, 7-9 voltammetry, 10 polarography 11 and spectrophotometry. [12] [13] [14] [15] [16] [17] [18] Nowadays, more strict regulation related to the quality control of pharmaceuticals has led to increasing demands for the automation of the analytical assays carried out in appropriate control laboratories. Flow injection analysis (FIA) is a versatile instrumental tool due to its simplicity, small sample volumes, low reagent consumption, and high reproducibility; such analysis generally allows the acquisition of a great number of analytical data at low cost and in a relatively short analysis time. 19 Flow injection procedures employing various types of detection has also been applied for novalgin analysis in pharmaceuticals, such as: amperometric, 20 turbidimetric, 21 potentiometric, 22 chemilumimetric, 23 fluorometric 24 and spectrophotometric 25, 26 detection. To the best of our knowledge, there are no reports on flow-injection spectrophotometric determination of novalgin in micellar media.
The analytical utility of micelles is evident in a wide variety of analytical techniques from instrumental to classical wet chemical methods of analysis. Micelles can increase the molar absorptivity of the chromophore, modify equilibrium constants and reaction yields, shift spectral bands, co-solubilize samples, reagents and products, and catalyze reactions. 27 The micellar medium can improve the spectrophotometric detection in flow injection analysis by providing an increase in the formation rate of the chromophore and an increase in the sensitivity. 27 In addition, the surfactants can also be useful in softening the experimental conditions required to carry out the reaction, such as: reducing the temperature or acid and reagent concentrations. 27, 28 This is of interest for simplification of manual and automated analytical procedures, and will contribute to green chemistry, 29 due to its capability of decreasing the reagent consumption and as a consequence, minimizing effluent generation.
The present work describes an FI spectrophotometric procedure for the determination of novalgin using sodium dodecyl sulfate (SDS) micellar medium to greatly improve the sensitivity of the condensation of p-dimethylaminocinnamaldehyde (p-DAC) with novalgin, in acid medium.
Experimental design approaches and the response surface analysis methodology were used as methods of maximizing the response.
The development and validation of the proposed FI spectrophotometric procedure in micellar medium and its application to novalgin determination in pharmaceuticals are described. The proposed procedure is highly sensitive, simple, and rapid, does not involve heating steps and has very small sample consumption when compared with other procedures.
Experimental

Apparatus
The flow-through measurements were carried out using an ASIA system from Ismatec (Zürich, Switzerland) equipped with a four-channel pump (IS 7610) with variable speed (1 -50 rpm) for propelling the fluids and a sample injection valve (IS 7630, Rheodyne 5041, USA). An HP 8453A (Hewlett Packard, USA) diode array UV/Vis spectrophotometer equipped with a flowcell of 10 mm path length and 80 μL inner volume from Hewlett Packard (Hewlett Packard, USA) was used for the continuously monitoring of the absorbance at 510 nm. The FIA peak is registered as the time-dependence of the absorbance at this wavelength.
The FI diagram is represented in Fig. 1 . The samples and the reagent (p-DAC 0.054% (m/v) prepared in HCl 2.22 × 10 -2 mol L -1 ) solutions were pumped through Tygon ® pumping tubes of 1.42 mm i.d., and the SDS 2.00 × 10 -2 mol L -1 solution was pumped through Tygon ® pumping tube of 2.06 mm i.d. The standard connectors, sample loop and reaction coils were made of polytetrafluoroethylene tubes (PTFE) of 0.8 mm i.d. Endfittings and connectors (Omnifit, New York, USA) were used.
Reagents and solutions
For the preparation of the solutions and samples, deionized water (Milli-Q Gradient system) and grade A glassware were used throughout. Analytical-reagent or pharmaceutical grade chemicals were used. The excipients used in the interference study were of pharmaceutical grade.
HCl stock solution 0.479 mol L -1 was prepared by convenient dilution of concentrated acid (Mallinckrodt, Xalostoc, Mexico) with deionized water and standardized by volumetric procedure. Working solutions were prepared by appropriate dilution of the stock solution with deionized water.
A standard novalgin solution (2.90 × 10 -4 mol L -1 ) was prepared by dissolving 10.0 mg of novalgin (Daiichi Seiyaku Co. Ltd., Tokyo, Japan, 99.9%) in 100 mL of deionized water and was standardized as described in the literature. 5 Working standard solutions (1.45 × 10 -6 to 2.90 × 10 -5 mol L -1 ) were obtained by measuring the appropriate volume of the novalgin stock solution. After that, 5 mL of SDS 0.10 mol L -1 was added and the volume was completed with water to 25 mL in a volumetric flask.
p-Dimethylaminocinnamaldehyde (p-DAC) (Aldrich, Milwaukee, USA) 0.054% (m/v) was prepared in HCl 2.22 × 10 -2 mol L -1 (Mallinckrodt, Xalostoc, Mexico) and it was kept refrigerated no more than 1 week.
Sodium dodecyl sulfate (SDS) (Sigma, St. Louis, USA) aqueous solutions (1.00 × 10 -1 mol L -1 ) were prepared weekly. Working solutions were prepared by appropriate dilution of the stock solution with deionized water.
Recommended procedure
For the flow injection procedure, the following optimum conditions are suggested ( After that, the carrier stream merged with a reagent stream of p-DAC 0.054% (m/v) prepared in HCl 2.22 × 10 -2 mol L -1 pumped by a peristaltic pump (PP) at 1.70 mL min -1 . The mixture passed through the reaction coil (RC, 250 cm) at room temperature and the red-orange product that formed was carried to the flow injection spectrophotometric cell. The absorbance of the colored product was measured at 510 nm in the detector previously adjusted to zero with the carrier SDS solution converging with the reagent stream in the absence of novalgin. The absorbance was recorded continuously on a computer.
A series of novalgin standard solutions was injected into the reagent stream via an injection valve. The product formed was continuously monitored. A standard calibration graph was prepared by plotting peak height versus novalgin concentration over the range of 1.45 × 10 -6 to 2.90 × 10 -5 mol L -1 (equivalent to 0.5 -10.0 μg mL -1 ).
Sample preparation and analytical applications
Samples of pharmaceutical formulations (A -G) containing novalgin in several dosage forms, both solid and liquid, were purchased in local drugstores in Araraquara city (Brazil) and analyzed by the proposed method.
Tablets.
Twenty tablets of each commercial brand pharmaceutical to be studied were weighed exactly and grounded to a fine powder. A portion of this powder equivalent to approximately 2.5 mg of novalgin was accurately weighed. The sample was shaken with 10 mL of deionized water in a magnetic stirrer for 5 min and diluted with deionized water in a 25 mL volumetric flask. In the sequence, this solution was filtered through Whatman 42 filter paper and an aliquot of 1.25 mL of filtrate was transferred to a 25 mL volumetric flask and 5 mL of SDS 0.10 mol L -1 was added and the volume was completed with water. This solution was analyzed according to 1384 ANALYTICAL SCIENCES DECEMBER 2007, VOL. 23 
Reference method
For accuracy assessment of the results obtained by the proposed method, novalgin pharmaceutical formulations were analyzed using the iodometric reference method. 5 
Results and Discussion
Novalgin ((I), Scheme 1) is an aromatic tertiary amine; in aqueous solutions, it readily undergoes hydrolysis, 30 forming the 4-methylaminoantipyrine ((II), Scheme 1), 31 a secondary aromatic amine, which can react with p-DAC. The reaction between secondary aromatic amines and p-DAC is assumed to take place via the condensation of the protonated secondary amino group with the carbonyl group of the reagent to produce an imminium salt. [32] [33] [34] The probable mechanism for this reaction is shown in Scheme 1, which is to a large extent based on reactions suggested in the literature. [32] [33] [34] It is known that micellar media are capable of changing the equilibrium, kinetic and spectral properties of reactions in which they are involved, and this has been used to improve the characteristics of analytical procedures. 27 The effect of surfactant micelles in the condensation of aldehydes, such as p-DAC, with amines has been subject of a number of publications. [35] [36] [37] However, there are no reports on the use of the micelles in the condensation of novalgin with p-DAC.
Preliminary experiments revealed that, in the presence of SDS, a significant enhancement of more than five orders of magnitude in the sensitivity of the reaction was observed and no shift in the absorption maximum takes place (Fig. 2) .
On the basis of these results, a new flow injection procedure with spectrophotometric detection was developed based on the condensation reaction of novalgin with p-DAC in micellar medium and diluted acid solution.
Optimization
For the optimization of the flow injection method, the FI parameters and the chemical variables were investigated separately. The optimization was developed by experimental design, including two kinds of designs: the factorial design to evaluate which of the variables were significant factors and the central composite design, to obtain the response surface from which the optimal factors that give a maximum response can be deduced.
Optimization of FI parameters
Preliminary experiments under continuous flow conditions were carried out to test the manifold configuration and the approximate ranges of the tested parameters. The design of the manifold selected is shown in Fig. 1 . The best results were obtained when the sample was injected into a stream of SDS carrier and then combined by merging the carrier with the stream of mixed p-DAC/HCl reagent. In this experiment, the carrier stream of SDS was pumped at a flow rate higher than that of the reagent stream of p-DAC/HCl. Adopting this strategy, a stable baseline and an effective mixing of the sample and reagent solutions were achieved, affording an acceptable peak shape and sampling rate. In addition to the improvement in the analytical performance, this strategy enabled the reduction of the reagent consumed per determination.
The factors affecting the FI procedure were examined initially by a 2 3 factorial design. The variables together with the levels examined are given in Table 1 . For this design, eight experiments were necessary, which were realized in triplicate and randomized to eliminate environmental variation. In this study, the concentrations of reagents were kept constant: p-DAC 0.040% (m/v) prepared in HCl 1.20 × 10 -2 mol L -1 , SDS 0.02 mol L -1 and novalgin solution 2.90 × 10 -5 mol L -1 . The response selected was the absorbance intensity.
The influence of the sample volume on the transient peak was studied by changing the length of the sampling loop. Based on the previous experiments in the FI system with respect to the flow rate of the carrier and reagent solutions, we knew that the best results could be obtained when the flow rate of SDS carrier was higher than that of the p-DAC/HCl reagent. So, Tygon ® tubes of the 2.06 and 1.42 mm i.d. were used to propel SDS and p-DAC/HCl solutions, respectively. The optimal total flow rate (carrier plus reagent streams) was determined by varying the rotation speed of the peristaltic pump producing the total flow rate, as shown in Table 1 .
The effects of the individual factors and their combinations were determined using the Statistic program. The results are represented in a Pareto chart (Fig. 3) , which is a horizontal barchart. The length of each bar on the chart is proportional to the absolute value of its associated estimated effect or the standardized effect. The chart includes a vertical line that corresponds to the 95% limit indicating statistical significance. An effect is therefore significant if its corresponding bar crosses 1385 ANALYTICAL SCIENCES DECEMBER 2007, VOL. 23 . Measurements taken at 25˚C. this vertical line. The most important effects correspond to the sample loop and the reaction coil (Fig. 3) . Hence, these effects were studied more carefully. Since the total flow rate did not have an important effect, a total flow rate of 5.00 mL min -1 was chosen, producing a flow with acceptable peak shapes, sensitivity, reagent consumption and reaction time.
The central composite design was implemented to investigate the effect of the sample loop and the reaction coil on the absorbance signal, aiming at the highest sensitivity, in which the two variables were codified in five levels including four central points. For this design proposal, the variables considered and the levels examined are given in Table 2 . Figure 4 shows the response surface estimated as a function of the sample loop and the reaction coil. A statistically significant quadratic model accounting for 99.2% of the variance was fitted to the data at a 95.0% confidence level. Analyzing the fitted surface, it is possible to identify the points referring to the best conditions, which were a sample loop of the 880 μL and a reaction coil of 250 cm.
Optimization of chemical variables
The factors affecting the sensitivity of colored product resulting from the reaction of the novalgin with p-DAC, in the presence of SDS in acid medium, were carefully studied. This study was conducted using the already optimized conditions (sample loop, reaction coil and total flow rate). For this purpose, a 2 3 factorial design was utilized. The factors and their examined levels are given in Table 3 . For each factor, an upper (+1) and a lower (-1) level were selected based on preliminary experiments carried out in our laboratory. For this design, eight experiments were necessary, which were carried out in triplicate and randomized to eliminate the environmental variations. The final concentration of novalgin was kept constant at 2.90 × 10 -5 mol L -1 in all experiments.
The individual effects of the various parameters as well as their interactions can be discussed from the Pareto chart illustrated in Fig. 5 . From Fig. 5 , it is obvious that the p-DAC concentration was the most significant factor, with a positive impact, indicating that the best results can be obtained when this factor is adjusted to a high level (+1). The individual effect of the HCl concentration also was significant with a positive impact. The individual effect of the SDS concentration and the interaction effects between all factors also were significant, but less 1386 ANALYTICAL SCIENCES DECEMBER 2007, VOL. 23 important. So, the SDS concentration was set at 2.00 × 10 -2 mol L -1 (the highest concentration level studied). In the sequence, a new central composite design was evaluated to investigate the effect of p-DAC and HCl concentrations on the absorbance signal, in which the two variables were codified in five levels including four central points. For this design, the variables considered and their examined levels are given in Table 4 . Figure 6 shows the response surface estimated as a function of HCl and p-DAC concentrations. A statistically significant quadratic model accounting for 89.0% of the variance was fitted to the data at a 95% confidence level. Analyzing the fitted surface, it is possible to identify that the points referring to the best conditions were: p-DAC 0.054% (m/v) prepared in HCl 2.22 × 10 -2 mol L -1 , which showed the highest absorbance values.
Analytical data
The developed analytical method was validated by evaluating the linear dynamic range, precision, limit of detection (LOD) and limit of quantification (LOQ) as well as by applying the standard addition technique.
Under the optimized experimental conditions (shown in Fig.  1) , the linear calibration curve was constructed from 1.45 × 10 Assay precision was defined by determining intraday and interday variation, expressed as relative standard deviation (RSD). The interday variation was evaluated over 3 days. The intraday precision and interday precision were studied from 10 replicate analyses of 1.45 × 10 -5 mol L -1 novalgin solution. The coefficients of variation were 0.7 and 1.2%, respectively. The smallest novalgin concentration on the calibration curve was analyzed by the proposed method (n = 20) and the standard deviations of the measurements were calculated and used to estimate the LOD and LOQ according to IUPAC recomendations. 38 The LOD and LOQ were 1.31 × 10 -7 and 4.40 × 10 -7 mol L -1 , respectively with an RSD of 2.0%. Repeatability of the proposed method was measured for a series of ten independent determinations at two concentration levels of a sample solution. The relative standard deviations were found to be 0.7 and 0.2% for the determination of 5.80 × 10 -6 and 1.45 × 10 -5 mol L -1 of novalgin, respectively. In order to investigate the presence of matrix effects on the proposed method, a recovery study was carried out. In this study, 1.00, 2.00, 3.00 and 4.00 μg mL -1 of novalgin reference solutions were added in four selected pre-analyzed pharmaceutical preparations. The results presented in Table 5 reveal the absence of significant matrix effects on the proposed FI procedure. 
Study of interferences
The effects of the common excipients and of the associated drugs commonly present in commercial pharmaceutical formulations involving novalgin were carefully examined. The concomitants studied were lactose, sucrose, citric acid, starch, sodium saccharin, sodium sulfite, sodium benzoate, talc, magnesium stearate, polyvinylpirrolidone, sorbitol, methyl cellulose, caffeine, aspirin, acetaminophen, ascorbic acid, phenacetin, oxyphenbutazone, acid promethazine hydrochloride, adiphenine hydrochloride, butylscopolamine bromide, salycilamide and phenobarbital. For this study, solutions containing novalgin and one of the concomitants taken separately in concentrations equal or 10 times greater than that of novalgin were shaken with deionized water in a magnetic stirrer for 5 min, diluted and filtered where it was necessary. These were analyzed under the same conditions as those described in the recommended procedure.
The effect of each excipient was considered to be an interference when the signal showed an error greater than or equal to 3.0% in the determination of the drug.
No interferences were observed in the presence of the substances tested.
Analytical application
The applicability of the proposed method for the determination of novalgin in commercial dosage forms was examined by analyzing marketed products. The results were statistically 39 compared with those obtained by the iodometric reference method 5 and are summarized in Table 6 . It is evident that the calculated t and F values are less than the theoretical ones at 95% confidence level, indicating that there is no significant difference between either methods concerning precision and accuracy in the determination of novalgin in pharmaceutical formulations.
The flow system selected provides a sampling frequency of 72 samples h -1 . Compared with previously reported methods for the determination of novalgin the proposed method was more sensitive (lower detection limit) than other FI methods reported in literature (Table 7) .
Conclusions
The sensitivity of the reaction between novalgin and p-DAC in dilute acid medium was increased approximately 5.6-fold in micellar SDS medium and this effect was exploited to develop a very sensitive spectrophotometric FI procedure (LOD = 1.31 × 10 -7 mol L -1 ) for novalgin quantification. The proposed FI spectrophotometric method has the advantages of simplicity, high sampling rate (72 samples h -1 ), high sensitivity, and repeatability; it generates low levels of waste and does not involve specific or complex pretreatment of the samples.
Its usefulness for novalgin determination in commercial liquid and solid dosage forms was demonstrated, suggesting its use as a reliable and advantageous alternative to most other previously reported methods. . c. Average ± standard deviation (SD) of three independent analyses. d. Theoretical values of t and F at 95% confidence level. Ref.
